Syntaxin-1B (STX1B)

📖 Wiki Page

protein1281 wordssynced 2026-04-02

Syntaxin-1B (STX1B)

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Syntaxin-1B (STX1B)</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Syntaxin-1B</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>[STX1B](/proteins/stx1b-protein)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[P61264](https://www.uniprot.org/uniprot/P61264)</td>
</tr>
<tr>
<td class="label">PDB Structure ID</td>
<td>[1BR0](https://www.rcsb.org/structure/1BR0), [3C98](https://www.rcsb.org/structure/3C98)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>35.6 kDa</td>
</tr>
<tr>
<td class="label">Amino Acids</td>
<td>288</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Presynaptic plasma membrane, Synaptic vesicles</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Syntaxin family, SNARE proteins</td>
</tr>
<tr>
<td class="label">Brain Expression</td>
<td>[Cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus), Cerebellum, Basal ganglia</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Alzheimer's Disease, Parkinson's Disease, ALS, Epilepsy</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus (CA1, CA3)</td>
<td>High</td>
</tr>
<tr>
<td cla

...

Syntaxin-1B (STX1B)

Introduction

Syntaxin-1B (STX1B) is a critical SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) protein essential for synaptic vesicle fusion and neurotransmitter release. As a member of the syntaxin family, STX1B plays a fundamental role in presynaptic terminal function and is implicated in various neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). This page provides comprehensive coverage of STX1B structure, function, mechanisms, and therapeutic relevance.
title: Syntaxin-1B (STX1B)
.infobox.infobox-protein

Overview

Syntaxin-1B is a presynaptic membrane protein that mediates synaptic vesicle fusion through formation of the SNARE complex. STX1B is widely expressed throughout the central nervous system, with particularly high expression in the cerebral cortex, hippocampus, cerebellum, and basal ganglia [@binz1993]. The protein is localized to the presynaptic plasma membrane where it interacts with SNAP-25 and VAMP2 to form the core SNARE complex responsible for Ca²⁺-triggered neurotransmitter release.

STX1B exists in two major isoforms (STX1B-1 and STX1B-2) generated by alternative splicing, which exhibit slightly different expression patterns and functional properties [@greaves2012]. The protein is essential for normal synaptic transmission, and dysregulation of STX1B function has been implicated in multiple neurodegenerative diseases.

Structure

Domain Architecture

The STX1B protein contains several distinct structural domains:

N-terminal Habc Domain (residues 1-154): A three-helix bundle (Habc) that regulates SNARE complex assembly through intramolecular interactions. This domain folds back onto the SNARE motif in the "closed" conformation, preventing premature complex formation [@dulubova1999].

SNARE Motif (residues 155-253): The central coiled-coil region that participates in SNARE complex formation. This highly conserved region contains 16 layered hydrophobic residues (the "0 layer") at the center that form the structural core of the SNARE complex [@sutton1998].

Transmembrane Anchor (residues 267-288): A single C-terminal transmembrane helix that anchors STX1B to the presynaptic plasma membrane.

Structural Conformations

STX1B adopts two primary conformational states:

Closed conformation: The Habc domain folds back to interact with the SNARE motif, preventing SNARE complex assembly
Open conformation: The Habc domain disengages, allowing SNARE motif to participate in complex formation

This conformational switching is regulated by interactions with Munc13, Munc18, and other regulatory proteins [@rizo2018].

Normal Function

Synaptic Vesicle Fusion

STX1B is a central component of the neurotransmitter release machinery:

SNARE Complex Assembly: STX1B (Q-SNARE) forms a ternary complex with SNAP-25 (two Q-SNAREs) and VAMP2 (R-SNARE). The complex zipper progresses from N-terminus to C-terminus, bringing the synaptic vesicle and plasma membranes into close proximity [@jahn2003].

Membrane Fusion: The SNARE complex undergoes structural transitions that drive membrane fusion, with the transmembrane domains of STX1B and VAMP2 facilitating lipid mixing.

Ca²⁺ Triggering: Although the core SNARE complex mediates fusion, synaptotagmin-1 serves as the Ca²⁺ sensor that triggers rapid fusion upon action potential arrival.

Regulation of Release

STX1B function is tightly regulated by multiple mechanisms:

Munc18-1 binding: STX1B interacts with Munc18-1, which is essential for SNARE complex assembly and synaptic vesicle priming [@shen2007]
Complexin binding: Complexin stabilizes the SNARE complex in a fusion-competent state
Phosphorylation: STX1B phosphorylation by casein kinases modulates release probability

Additional Functions

Beyond synaptic transmission, STX1B participates in:

Axonal transport: KIF2A motor domain interactions mediate microtubule-based transport
[Autophagy](/entities/autophagy): STX17 (related syntaxin) mediates autophagosome-lysosome fusion
Lysosomal trafficking: Syntaxin proteins regulate endosomal and lysosomal fusion events

Role in Disease

Alzheimer's Disease

STX1B dysfunction contributes to multiple aspects of AD pathogenesis:

Synaptic Failure: Early synaptic dysfunction in AD involves impaired SNARE complex formation. [Aβ](/proteins/amyloid-beta) oligomers directly interact with STX1B and SNAP-25, disrupting the pre-synaptic release machinery [@parodi2010]. Studies show reduced STX1B levels in AD temporal cortex, correlating with cognitive decline.

Axonal Transport Defects: [Tau](/proteins/tau) pathology disrupts STX1B transport in axons. Hyperphosphorylated [tau](/proteins/tau) impairs kinesin-based transport of STX1B-containing vesicles, contributing to presynaptic dysfunction.

Therapeutic Implications: Enhancing SNARE complex formation represents a potential therapeutic strategy. Small molecules that stabilize STX1B-SNAP-25 interactions are under investigation.

Parkinson's Disease

In PD, STX1B dysfunction relates to:

Synaptic Vesicle Recycling: STX1B is essential for normal synaptic vesicle endocytosis and recycling. PD-linked mutations in genes like LRRK2 affect synaptic vesicle dynamics involving STX1B.

Dysautonomia: STX1B is expressed in autonomic [neurons](/entities/neurons), and its dysfunction may contribute to gastrointestinal symptoms in PD.

Amyotrophic Lateral Sclerosis (ALS)

STX1B alterations in ALS include:

Impaired Transport: Mutations in dynein/dynactin disrupt STX1B axonal transport, leading to presynaptic deficits.

Synaptic Hyperexcitability: Altered STX1B and SNARE complex stoichiometry may contribute to hyperexcitability observed in ALS motor neurons.

Epilepsy

STX1B mutations cause familial epilepsy [@schubert2016]. Loss-of-function variants disrupt synaptic inhibition and excitation balance, lowering seizure threshold.

Interaction Network

Core SNARE Partners

VAMP2 (Synaptobrevin-2): R-SNARE partner in the core complex
SNAP-25: Q-SNARE partner providing two coiled-coil domains
SNAP-23: Alternative Q-SNARE in non-neuronal cells

Regulatory Proteins

Munc18-1 (STXBP1): Essential scaffolding protein
Munc13-1: Priming factor that opens STX1B
Complexin-1/2: Clamp that stabilizes SNARE complexes
Synaptotagmin-1: Ca²⁺ sensor for triggered release

Motor Proteins

KIF2A: Kinesin that transports STX1B-containing vesicles
Dynein: Retrograde transport motor

Disease-Associated Interactions

[APP](/entities/app-protein): Amyloid precursor protein interactions
[Tau](/proteins/tau) (MAPT): Pathological interactions affecting transport
[α-Synuclein](/proteins/alpha-synuclein) (SNCA): Synucleinopathies affect SNARE function

Brain Region Distribution

STX1B expression varies across brain regions:

Therapeutic Targeting

Current Approaches

No FDA-approved drugs directly target STX1B, but several strategies are in development:

SNARE Complex Stabilizers: Small molecules that enhance SNARE complex formation are being investigated for AD and PD [@yang2019].

Gene Therapy: AAV-mediated STX1B delivery to restore synaptic function in neurodegeneration.

Kinase Inhibitors: Targeting kinases that phosphorylate SNARE proteins (e.g., casein kinase 2).

Challenges

[Blood-brain barrier](/entities/blood-brain-barrier) penetration
Specificity for STX1B over other syntaxins
Maintaining physiological regulation of release

Research Directions

Current research focuses on:

Cryo-EM structure of native SNARE complexes
Single-molecule studies of fusion dynamics
Patient-derived neurons modeling STX1B dysfunction
High-throughput screening for SNARE modulators

Background

The study of Syntaxin 1B (Stx1B) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[UniProt: P61264](https://www.uniprot.org/uniprot/P61264)
[PDB: 1BR0](https://www.rcsb.org/structure/1BR0)
[PDB: 3C98](https://www.rcsb.org/structure/3C98)
[NCBI Gene: STX1B](https://www.ncbi.nlm.nih.gov/gene/?term=STX1B)
[HGNC: STX1B](https://www.genenames.org/data/hgnc_data.php/hgnc_id:11411)

References

[Binz T, et al, (1993) (1993)](https://pubmed.ncbi.nlm.nih.gov/825467/)

[Greaves J, et al, (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22260663/)

[Dulubova I, et al, (1999) (1999)](https://pubmed.ncbi.nlm.nih.gov/10449403/)

[Sutton RB, et al, (1998) (1998)](https://pubmed.ncbi.nlm.nih.gov/9783588/)

[Rizo J, et al, (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29358743/)

[Jahn R, et al, (2003) (2003)](https://pubmed.ncbi.nlm.nih.gov/12600314/)

[Shen J, et al, (2007) (2007)](https://pubmed.ncbi.nlm.nih.gov/17218258/)

[Parodi J, et al, (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20231275/)

[Schubert J, et al, (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27689012/)

[Yang Y, et al, (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31625781/)

📖 View canonical wiki page →

Syntaxin-1B (STX1B)

Syntaxin-1B (STX1B)

Introduction

Syntaxin-1B (STX1B)

Introduction

Overview

Structure

Domain Architecture

Structural Conformations

Normal Function

Synaptic Vesicle Fusion

Regulation of Release

Additional Functions

Role in Disease

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Epilepsy

Interaction Network

Core SNARE Partners

Regulatory Proteins

Motor Proteins

Disease-Associated Interactions

Brain Region Distribution

Therapeutic Targeting

Current Approaches

Challenges

Research Directions

Background

See Also

External Links

References